Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Bossuyt · SciRah

Researcher profile · Semantic Scholar

V. Bossuyt

Share profile

V. Bossuyt — researcher profile on SciRah

h-index: 22
Works: 73
Citations: 3,802

Most-cited papers

Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group
S. Hendry, R. Salgado, T. Gevaert, P. Russell +97 more
2017Advances in Anatomic Pathology611 citations Open access
Semantic Scholar
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
M. Dieci, N. Radosevic-Robin, S. Fineberg, G. G. Van den Eynden +24 more
2017Seminars in Cancer Biology402 citations Open access
Semantic Scholar
PD-L1 expression correlates with tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy in breast cancer
Hallie Wimberly, Jason R. Brown, K. Schalper, H. Haack +6 more
2014Cancer immunology research338 citations Open access
Semantic Scholar
A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer
A. Chagpar, B. Killelea, T. Tsangaris, M. Butler +8 more
2015New England Journal of Medicine333 citations Open access
Semantic Scholar
Immunological differences between primary and metastatic breast cancer
B. Szekely, V. Bossuyt, Xiaotong Li, V. Wali +12 more
2018Annals of Oncology298 citations Open access
Semantic Scholar
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
E. Provenzano, V. Bossuyt, G. Viale, D. Cameron +15 more
2015Modern Pathology276 citations Open access
Semantic Scholar
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
V. Bossuyt, E. Provenzano, W. Symmans, J. Boughey +16 more
2015Annals of Oncology213 citations Open access
Semantic Scholar
Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Jason R. Brown, Hallie Wimberly, D. Lannin, C. Nixon +2 more
2014Clinical Cancer Research153 citations Open access
Semantic Scholar
Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group
S. Hendry, Roberto Salgado, T. Gevaert, P. Russell +97 more
2017Advances in Anatomic Pathology135 citations Open access
Semantic Scholar
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
Emily S. Reisenbichler, Gang Han, A. Bellizzi, V. Bossuyt +20 more
2020Modern Pathology124 citations Open access
Semantic Scholar
CECR2 Drives Breast Cancer Metastasis by Promoting NF-κB Signaling and Macrophage-mediated Immune Suppression
Mei-Ling Zhang, Zong-Zhi Z. Liu, K. Aoshima, Wesley L. Cai +19 more
2022Science Translational Medicine120 citations Open access
Semantic Scholar
Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to Preoperative Trastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer
V. Varadan, H. Gilmore, K. Miskimen, D. Tuck +10 more
2016Clinical Cancer Research101 citations Open access
Semantic Scholar
Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy
R. Lindner, Catherine A. Sullivan, O. Offor, K. Lezon-Geyda +7 more
2013PLoS ONE85 citations Open access
Semantic Scholar
Increased epigenetic age in normal breast tissue from luminal breast cancer patients
E. Hofstatter, S. Horvath, D. Dalela, Piyush Gupta +14 more
2018Clinical Epigenetics54 citations Open access
Semantic Scholar
Metaplastic Breast Cancer: A Review.
H. Thomas, Bonnie Hu, Baris Boyraz, A. Johnson +3 more
2023Critical reviews in oncology/hematology53 citations
Semantic Scholar
Interobserver variability in breast carcinoma grading results in prognostic stage differences.
K. Rabe, Olivia L. Snir, V. Bossuyt, M. Harigopal +2 more
2019Human Pathology42 citations
Semantic Scholar
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer
T. Sanft, B. Aktaş, B. Schroeder, V. Bossuyt +10 more
2015Breast Cancer Research and Treatment38 citations Open access
Semantic Scholar
Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer
M. von Wahlde, K. Timms, A. Chagpar, V. Wali +10 more
2016Clinical Cancer Research31 citations Open access
Semantic Scholar
Molecular Predictors of Response to Therapy for Breast Cancer
N. Galanina, V. Bossuyt, L. Harris
2011Cancer Journal30 citations
Semantic Scholar
Standardizing of Pathology in Patients Receiving Neoadjuvant Chemotherapy
V. Bossuyt, W. Symmans
2016Annals of Surgical Oncology28 citations
Semantic Scholar
Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab
Huan Cheng, Ya-Lai Bai, W. Sikov, N. Sinclair +4 more
2014BMC Cancer25 citations Open access
Semantic Scholar
Processing and Reporting of Breast Specimens in the Neoadjuvant Setting.
V. Bossuyt
2017Surgical Pathology Clinics23 citations
Semantic Scholar
Breast Carcinoma With Chondroid Differentiation: A Clinicopathologic Study of 21 Triple Negative (ER−, PR−, Her2/neu−) Cases
K. Gwin, D. Wheeler, V. Bossuyt, F. Tavassoli
2010International Journal of Surgical Pathology22 citations
Semantic Scholar
Adenofibroma of the Fimbria: A Common Entity That Is Indistinguishable From Ovarian Adenofibroma
V. Bossuyt, F. Medeiros, R. Drapkin, A. Folkins +2 more
2008International Journal of Gynecological Pathology21 citations
Semantic Scholar
Breast cancer histopathology is predictive of low‐risk Oncotype Dx recurrence score
Parker C. Wilson, A. Chagpar, A. Çiçek, V. Bossuyt +5 more
2018The Breast Journal20 citations Open access
Semantic Scholar
Brief‐exposure to preoperative bevacizumab reveals a TGF‐β signature predictive of response in HER2‐negative breast cancers
V. Varadan, S. Kamalakaran, H. Gilmore, N. Banerjee +12 more
2016International Journal of Cancer20 citations Open access
Semantic Scholar
Primary osteosarcoma of the ovary: a case report and literature review.
O. Fadare, V. Bossuyt, M. Martel, V. Parkash
2007International Journal of Gynecological Pathology20 citations
Semantic Scholar
Economic Impact of Routine Cavity Margins Versus Standard Partial Mastectomy in Breast Cancer Patients
A. Chagpar, N. Horowitz, B. Killelea, T. Tsangaris +13 more
2017Annals of Surgery19 citations Open access
Semantic Scholar
Metastatic serous carcinoma presenting as inflammatory carcinoma over the breast—Report of two cases and literature review
G. Panse, V. Bossuyt, C. Ko
2018Journal of cutaneous pathology17 citations
Semantic Scholar
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
Swati Gupta, V. Neumeister, J. McGuire, Yan-S. Song +8 more
2019npj Breast Cancer16 citations Open access
Semantic Scholar
Pathologic evaluation of response to neoadjuvant therapy drives treatment changes and improves long‐term outcomes for breast cancer patients
V. Bossuyt, L. Spring
2020The Breast Journal15 citations Open access
Semantic Scholar
Cancerous ‘floater’: a lesson learned about tissue identity testing, endometrial cancer and microsatellite instability
V. Bossuyt, N. Buza, N. Ngo, M. Much +3 more
2013Modern Pathology12 citations Open access
Semantic Scholar
Macrodissection prior to Closed System RT-qPCR is not necessary for Estrogen Receptor and HER2 Concordance with IHC/FISH in Breast Cancer
Swati Gupta, Navin Mani, D. Carvajal-Hausdorf, V. Bossuyt +6 more
2018Laboratory Investigation11 citations Open access
Semantic Scholar
Locally recurrent secretory carcinoma of the breast.
Lindsey Mortensen, Zehra Ordulu, I. Dagogo-Jack, V. Bossuyt +8 more
2021The Oncologist10 citations Open access
Semantic Scholar
Mutation based treatment recommendations from next generation sequencing data: a comparison of web tools
Jaymin Patel, Joshua Knopf, Eric Reiner, V. Bossuyt +13 more
2016OncoTarget10 citations Open access
Semantic Scholar
Neoadjuvant weekly nab-paclitaxel (wA), carboplatin (Cb) plus bevacizumab (B) with or without dose-dense doxorubicin-cyclophosphamide (ddAC) plus B in ER+/HER2-negative (HR+) and triple-negative (TN) breast cancer (BrCa): A BrUOG study.
N. Sinclair, M. Abu-Khalaf, T. Rizack, K. Rosati +11 more
201210 citations
Semantic Scholar
Intra- and Interlaboratory Reproducibility of the Sensitivity to Endocrine Therapy Assay for Stage II/III Breast Cancer.
V. Bossuyt, R. Lau, Brandon Young, J. Howe +6 more
2021Clinical Chemistry8 citations Open access
Semantic Scholar
Use of p63, a myoepithelial cell marker, in determining the invasiveness of spontaneous mammary neoplasia in a rhesus macaque (Macaca mulatta).
Misty J. Williams-Fritze, Jodi A. Carlson Scholz, V. Bossuyt, C. Booth
2011Journal of the American Association for Laboratory Animal Science7 citations
Semantic Scholar
COX-2 expression in post-mastectomy chest wall relapse
J. Kim, V. Bossuyt, D. Lannin, B. Haffty
20057 citations
Semantic Scholar
Abstract PD10-01: The PEARL trial: Pre-operative pembrolizumab with radiation therapy in early stage triple negative breast cancer
H. McArthur, S. Shiao, S. Karlan, R. Basho +22 more
2022Cancer Research6 citations
Semantic Scholar
The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population
Kassidy Beyerlin, R. Jimenez, Mark L. Zangardi, G. Fell +10 more
2020Journal of Oncology Pharmacy Practice6 citations
Semantic Scholar
The Neoadjuvant Model and Complete Pathologic Response in Breast Cancer: All or Nothing?
V. Bossuyt, C. Hatzis
2016JAMA Oncology6 citations
Semantic Scholar
Multicenter phase II trial of neoadjuvant carboplatin, weekly nab-paclitaxel, and trastuzumab in stage II-III HER2+ breast cancer: A BrUOG study.
N. Sinclair, B. Sakr, M. Abu-Khalaf, G. Somlo +15 more
20136 citations
Semantic Scholar
Management of recurrent bilateral multifocal pseudoangiomatous stromal hyperplasia (PASH)
Xiaolu Xu, Sarah M. Persing, O. Allam, K. Park +4 more
2020The Breast Journal5 citations Open access
Semantic Scholar
Abstract PD5-01: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays in triple negative breast cancer
Emily S. Reisenbichler, Gang Han, V. Pelekanou, V. Yaghoobi +20 more
2020Poster Spotlight Session Abstracts5 citations
Semantic Scholar
Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab
Huan Cheng, Ya-Lai Bai, W. Sikov, N. Sinclair +4 more
2014BMC Cancer4 citations Open access
Semantic Scholar
Reproducibility of homologous recombination deficiency (HRD) scores in biopsies of triple negative breast cancer (TNBC) tumors.
K. Timms, A. Chagpar, V. Wali, V. Bossuyt +6 more
20153 citations
Semantic Scholar
Evaluation of gene expression by RNA-seq after single dose of trastuzumab (T) reveals predictors of pathologic complete response (pCR) in HER2-positive early breast cancer.
N. Galanina, Emmett Sprecher, V. Bossuyt, S. Sarkar +5 more
20123 citations
Semantic Scholar
Selection biases in the systematic collection of breast biobank specimens.
Yael Bar, Gary X. Wang, G. E. Gioia, V. Bossuyt +6 more
2023Journal of Clinical Oncology2 citations
Semantic Scholar
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
K. El Bairi, H. R. Haynes, E. Blackley, S. Fineberg +496 more
2021npj Breast Cancer2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Rimm×13
Invite
D. Rimm — researcher profile on SciRah
L. Pusztai×12
Invite
L. Pusztai — researcher profile on SciRah
D. Lannin×9
Invite
D. Lannin — researcher profile on SciRah
L. Harris×9
Invite
L. Harris — researcher profile on SciRah

×8

Invite

M. Abu-Khalaf — researcher profile on SciRah

Invite

A. Chagpar — researcher profile on SciRah

Invite

C. Hatzis — researcher profile on SciRah

Invite

W. Symmans — researcher profile on SciRah

Invite

W. Sikov — researcher profile on SciRah

Invite

S. Demaria — researcher profile on SciRah

Invite

S. Badve — researcher profile on SciRah

Invite

C. Denkert — researcher profile on SciRah